EMD-66894

Single-particle
2.83 Å
EMD-66894
3D View Gallery
Deposition: 02/11/2025
Map released: 12/08/2026
Last modified: 12/08/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-66894

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9xi2 summary report (pdf.gz) Map-9xi2 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 Omicron BA.4/5 spike RBD in complex with C807 Fab and ACE2

EMD-66894

Single-particle
2.83 Å
EMD-66894
3D View Gallery
Deposition: 02/11/2025
Map released: 12/08/2026
Last modified: 12/08/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 Omicron BA.4/5 spike RBD in complex with C807 Fab and ACE2
Fitted models: 9xi2

Deposition Authors: Niu C, Liu B, Gao X, Li Z, He J, Xiong X

AI identifies Elite Antibodies that Tolerate Escape Mutations from a Population Antibody Class Exerting Continued Selection Over SARS-CoV-2
Niu C, Huang X, Yan Q, Liu B, Gao X, Song Y, Wang J, Wang L, Li Z, Zheng H, He P, Huang X, Yuan H, Zou B, Yang Y, Wu F, Yao Y, Chen X, Chen L, He J, Yao J, Zhao J, Xiong X
To Be Published